- Home
- COE vs ENLV Comparison
COE vs ENLV Comparison
Compare COE & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COE | ENLV |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | Singapore | Israel |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.1M | 249.3M |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | COE | ENLV |
|---|---|---|
| Price | $27.80 | $1.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 2.1K | ★ 330.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.60 | $0.66 |
| 52 Week High | $56.13 | $2.10 |
Technical Indicators
Market Signals| Indicator | COE | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 48.49 | 57.79 |
| Support Level | $27.19 | $1.00 |
| Resistance Level | $28.50 | $1.23 |
| Average True Range (ATR) | 0.97 | 0.07 |
| MACD | 0.33 | -0.00 |
| Stochastic Oscillator | 67.58 | 60.00 |
Price Performance
Historical ComparisonAbout COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.